Calweton Veterinary Services Limited Filleted accounts for Companies House (small and micro)

Calweton Veterinary Services Limited Filleted accounts for Companies House (small and micro)


false false false false false false false false false true false false false false false true false No description of principal activity 2018-10-01 Sage Accounts Production Advanced 2019 - FRS102_2014 60,000 48,000 2,169 50,169 9,831 12,000 17,671 1 17,672 17,672 17,671 xbrli:pure xbrli:shares iso4217:GBP 04540277 2018-10-01 2019-06-20 04540277 2019-06-20 04540277 2018-09-30 04540277 2017-10-01 2018-09-30 04540277 2018-09-30 04540277 core:NetGoodwill 2018-10-01 2019-06-20 04540277 bus:Director4 2018-10-01 2019-06-20 04540277 core:NetGoodwill 2018-09-30 04540277 core:NetGoodwill 2019-06-20 04540277 core:LandBuildings core:LongLeaseholdAssets 2018-09-30 04540277 core:PlantMachinery 2018-09-30 04540277 core:LandBuildings core:LongLeaseholdAssets 2019-06-20 04540277 core:PlantMachinery 2019-06-20 04540277 core:LandBuildings core:LongLeaseholdAssets 2018-10-01 2019-06-20 04540277 core:PlantMachinery 2018-10-01 2019-06-20 04540277 core:WithinOneYear 2019-06-20 04540277 core:WithinOneYear 2018-09-30 04540277 core:AfterOneYear 2019-06-20 04540277 core:AfterOneYear 2018-09-30 04540277 core:ShareCapital 2019-06-20 04540277 core:ShareCapital 2018-09-30 04540277 core:RetainedEarningsAccumulatedLosses 2019-06-20 04540277 core:RetainedEarningsAccumulatedLosses 2018-09-30 04540277 core:NetGoodwill 2018-09-30 04540277 core:CostValuation core:Non-currentFinancialInstruments 2018-09-30 04540277 core:AdditionsToInvestments core:Non-currentFinancialInstruments 2019-06-20 04540277 core:CostValuation core:Non-currentFinancialInstruments 2019-06-20 04540277 core:Non-currentFinancialInstruments 2019-06-20 04540277 core:Non-currentFinancialInstruments 2018-09-30 04540277 core:LandBuildings core:LongLeaseholdAssets 2018-09-30 04540277 core:PlantMachinery 2018-09-30 04540277 bus:Director1 2018-10-01 2019-06-20 04540277 bus:SmallEntities 2018-10-01 2019-06-20 04540277 bus:AuditExempt-NoAccountantsReport 2018-10-01 2019-06-20 04540277 bus:FullAccounts 2018-10-01 2019-06-20 04540277 bus:SmallCompaniesRegimeForAccounts 2018-10-01 2019-06-20 04540277 bus:PrivateLimitedCompanyLtd 2018-10-01 2019-06-20
COMPANY REGISTRATION NUMBER: 04540277
Calweton Veterinary Services Limited
Filleted Unaudited Financial Statements
20 June 2019
Calweton Veterinary Services Limited
Statement of Financial Position
20 June 2019
20 Jun 19
30 Sep 18
Note
£
£
Fixed assets
Intangible assets
5
9,831
12,000
Tangible assets
6
180,749
188,904
Investments
7
17,672
17,671
---------
---------
208,252
218,575
Current assets
Stocks
95,839
89,479
Debtors
8
313,411
297,514
Cash at bank and in hand
174,444
73,727
---------
---------
583,694
460,720
Creditors: amounts falling due within one year
9
489,315
418,982
---------
---------
Net current assets
94,379
41,738
---------
---------
Total assets less current liabilities
302,631
260,313
Creditors: amounts falling due after more than one year
10
1,167
12,145
Provisions
22,978
24,650
---------
---------
Net assets
278,486
223,518
---------
---------
Capital and reserves
Called up share capital
1,200
1,200
Profit and loss account
277,286
222,318
---------
---------
Shareholders funds
278,486
223,518
---------
---------
These financial statements have been prepared and delivered in accordance with the provisions applicable to companies subject to the small companies' regime and in accordance with FRS 102 'The Financial Reporting Standard applicable in the UK and Republic of Ireland'.
In accordance with section 444 of the Companies Act 2006, the statement of income and retained earnings has not been delivered.
For the period ending 20 June 2019 the company was entitled to exemption from audit under section 477 of the Companies Act 2006 relating to small companies.
Directors' responsibilities:
- The members have not required the company to obtain an audit of its financial statements for the period in question in accordance with section 476 ;
- The directors acknowledge their responsibilities for complying with the requirements of the Act with respect to accounting records and the preparation of financial statements .
Calweton Veterinary Services Limited
Statement of Financial Position (continued)
20 June 2019
These financial statements were approved by the board of directors and authorised for issue on 12 June 2020 , and are signed on behalf of the board by:
M Stanworth
Director
Company registration number: 04540277
Calweton Veterinary Services Limited
Notes to the Financial Statements
Period from 1 October 2018 to 20 June 2019
1. General information
The company is a private company limited by shares, registered in England and Wales. The address of the registered office is Leeman House, Station Business Park, Holgate Park Drive, York, YO26 4GB.
2. Statement of compliance
These financial statements have been prepared in compliance with Section 1A of FRS 102, 'The Financial Reporting Standard applicable in the UK and the Republic of Ireland'.
3. Accounting policies
Basis of preparation
The financial statements have been prepared on the historical cost basis, as modified by the revaluation of certain financial assets and liabilities and investment properties measured at fair value through profit or loss.
The financial statements are prepared in sterling, which is the functional currency of the entity.
Revenue recognition
Turnover is measured at the fair value of the consideration received or receivable for goods supplied and services rendered, net of discounts and Value Added Tax. Revenue from the sale of goods is recognised when the significant risks and rewards of ownership have transferred to the buyer (usually on despatch of the goods); the amount of revenue can be measured reliably; it is probable that the associated economic benefits will flow to the entity; and the costs incurred or to be incurred in respect of the transactions can be measured reliably.
Income tax
The taxation expense represents the aggregate amount of current and deferred tax recognised in the reporting period. Tax is recognised in profit or loss, except to the extent that it relates to items recognised in other comprehensive income or directly in equity. In this case, tax is recognised in other comprehensive income or directly in equity, respectively. Current tax is recognised on taxable profit for the current and past periods. Current tax is measured at the amounts of tax expected to pay or recover using the tax rates and laws that have been enacted or substantively enacted at the reporting date.
Deferred tax is recognised in respect of all timing differences at the reporting date. Unrelieved tax losses and other deferred tax assets are recognised to the extent that it is probable that they will be recovered against the reversal of deferred tax liabilities or other future taxable profits. Deferred tax is measured using the tax rates and laws that have been enacted or substantively enacted by the reporting date that are expected to apply to the reversal of the timing difference.
Operating leases
Lease income is recognised in profit or loss on a straight line basis over the lease term. The aggregate cost of lease incentives are recognised as a reduction to income over the lease term on a straight-line basis. Costs, including depreciation, incurred in earning the lease income are recognised as an expense. Any initial direct costs incurred in negotiating and arranging the operating lease are added to the carrying amount of the lease and recognised as an expense over the lease term on the same basis as the lease income.
Goodwill
Goodwill arises on business acquisitions and represents the excess of the cost of the acquisition over the company's interest in the net amount of the identifiable assets, liabilities and contingent liabilities of the acquired business. Goodwill is measured at cost less accumulated amortisation and accumulated impairment losses. It is amortised on a straight-line basis over its useful life. Where a reliable estimate of the useful life of goodwill or intangible assets cannot be made, the life is presumed not to exceed ten years.
Amortisation
Goodwill 5% straight line
If there is an indication that there has been a significant change in amortisation rate, useful life or residual value of an intangible asset, the amortisation is revised prospectively to reflect the new estimates.
Tangible assets
Tangible assets are initially recorded at cost, and subsequently stated at cost less any accumulated depreciation and impairment losses. Any tangible assets carried at revalued amounts are recorded at the fair value at the date of revaluation less any subsequent accumulated depreciation and subsequent accumulated impairment losses. An increase in the carrying amount of an asset as a result of a revaluation, is recognised in other comprehensive income and accumulated in equity, except to the extent it reverses a revaluation decrease of the same asset previously recognised in profit or loss. A decrease in the carrying amount of an asset as a result of revaluation, is recognised in other comprehensive income to the extent of any previously recognised revaluation increase accumulated in equity in respect of that asset. Where a revaluation decrease exceeds the accumulated revaluation gains accumulated in equity in respect of that asset, the excess shall be recognised in profit or loss.
Depreciation
Depreciation is calculated so as to write off the cost or valuation of an asset, less its residual value, over the useful economic life of that asset as follows:
Depreciation is calculated so as to write off the cost or valuation of an asset, less its residual value, over the useful life of that asset as follows: Leasehold Property - Over the term of the lease Hydrotherapy Pool - 25% straight line Fixtures & Fittings - 20% straight line Motor Vehicles - 20% straight line Surgical Equipment - 20% straight line Office Equipment - 33.3% straight line
Investments
Fixed asset investments are initially recorded at cost, and subsequently stated at cost less any accumulated impairment losses.
Listed investments are measured at fair value with changes in fair value being recognised in profit or loss.
Investments in associates
Investments in associates accounted for in accordance with the cost model are recorded at cost less any accumulated impairment losses. Investments in associates accounted for in accordance with the fair value model are initially recorded at the transaction price. At each reporting date, the investments are measured at fair value, with changes in fair value recognised in other comprehensive income/profit or loss. Where it is impracticable to measure fair value reliably without undue cost or effort, the cost model will be adopted. Dividends and other distributions received from the investment are recognised as income without regard to whether the distributions are from accumulated profits of the associate arising before or after the date of acquisition.
Investments in joint ventures
Investments in jointly controlled entities accounted for in accordance with the cost model are recorded at cost less any accumulated impairment losses. Investments in jointly controlled entities accounted for in accordance with the fair value model are initially recorded at the transaction price. At each reporting date, the investments are measured at fair value, with changes in fair value recognised in other comprehensive income/profit or loss. Where it is impracticable to measure fair value reliably without undue cost or effort, the cost model will be adopted. Dividends and other distributions received from the investment are recognised as income without regard to whether the distributions are from accumulated profits of the joint venture arising before or after the date of acquisition.
Impairment of fixed assets
A review for indicators of impairment is carried out at each reporting date, with the recoverable amount being estimated where such indicators exist. Where the carrying value exceeds the recoverable amount, the asset is impaired accordingly. Prior impairments are also reviewed for possible reversal at each reporting date. For the purposes of impairment testing, when it is not possible to estimate the recoverable amount of an individual asset, an estimate is made of the recoverable amount of the cash-generating unit to which the asset belongs. The cash-generating unit is the smallest identifiable group of assets that includes the asset and generates cash inflows that largely independent of the cash inflows from other assets or groups of assets. For impairment testing of goodwill, the goodwill acquired in a business combination is, from the acquisition date, allocated to each of the cash-generating units that are expected to benefit from the synergies of the combination, irrespective of whether other assets or liabilities of the company are assigned to those units.
Stocks
Stocks are measured at the lower of cost and estimated selling price less costs to complete and sell. Cost includes all costs of purchase, costs of conversion and other costs incurred in bringing the stock to its present location and condition.
Finance leases and hire purchase contracts
Assets held under finance leases and hire purchase contracts are recognised in the statement of financial position as assets and liabilities at the lower of the fair value of the assets and the present value of the minimum lease payments, which is determined at the inception of the lease term. Any initial direct costs of the lease are added to the amount recognised as an asset. Lease payments are apportioned between the finance charges and reduction of the outstanding lease liability using the effective interest method. Finance charges are allocated to each period so as to produce a constant rate of interest on the remaining balance of the liability.
Provisions
Provisions are recognised when the entity has an obligation at the reporting date as a result of a past event, it is probable that the entity will be required to transfer economic benefits in settlement and the amount of the obligation can be estimated reliably. Provisions are recognised as a liability in the statement of financial position and the amount of the provision as an expense. Provisions are initially measured at the best estimate of the amount required to settle the obligation at the reporting date and subsequently reviewed at each reporting date and adjusted to reflect the current best estimate of the amount that would be required to settle the obligation. Any adjustments to the amounts previously recognised are recognised in profit or loss unless the provision was originally recognised as part of the cost of an asset. When a provision is measured at the present value of the amount expected to be required to settle the obligation, the unwinding of the discount is recognised as a finance cost in profit or loss in the period it arises.
Financial instruments
A financial asset or a financial liability is recognised only when the company becomes a party to the contractual provisions of the instrument. Basic financial instruments are initially recognised at the transaction price, unless the arrangement constitutes a financing transaction, where it is recognised at the present value of the future payments discounted at a market rate of interest for a similar debt instrument. Debt instruments are subsequently measured at amortised cost. Where investments in non-convertible preference shares and non-puttable ordinary shares or preference shares are publicly traded or their fair value can otherwise be measured reliably, the investment is subsequently measured at fair value with changes in fair value recognised in profit or loss. All other such investments are subsequently measured at cost less impairment. Other financial instruments, including derivatives, are initially recognised at fair value, unless payment for an asset is deferred beyond normal business terms or financed at a rate of interest that is not a market rate, in which case the asset is measured at the present value of the future payments discounted at a market rate of interest for a similar debt instrument. Other financial instruments are subsequently measured at fair value, with any changes recognised in profit or loss, with the exception of hedging instruments in a designated hedging relationship.
Financial assets that are measured at cost or amortised cost are reviewed for objective evidence of impairment at the end of each reporting date. If there is objective evidence of impairment, an impairment loss is recognised in profit or loss immediately. For all equity instruments regardless of significance, and other financial assets that are individually significant, these are assessed individually for impairment. Other financial assets are either assessed individually or grouped on the basis of similar credit risk characteristics. Any reversals of impairment are recognised in profit or loss immediately, to the extent that the reversal does not result in a carrying amount of the financial asset that exceeds what the carrying amount would have been had the impairment not previously been recognised.
4. Employee numbers
The average number of persons employed by the company during the period amounted to 46 (2018: 47 ).
5. Intangible assets
Goodwill
£
Cost
At 1 October 2018 and 20 June 2019
60,000
--------
Amortisation
At 1 October 2018
48,000
Charge for the period
2,169
--------
At 20 June 2019
50,169
--------
Carrying amount
At 20 June 2019
9,831
--------
At 30 September 2018
12,000
--------
6. Tangible assets
Long leasehold property
Plant and machinery
Total
£
£
£
Cost
At 1 October 2018
252,038
356,083
608,121
Additions
25,036
25,036
---------
---------
---------
At 20 June 2019
277,074
356,083
633,157
---------
---------
---------
Depreciation
At 1 October 2018
140,551
278,666
419,217
Charge for the period
17,088
16,103
33,191
---------
---------
---------
At 20 June 2019
157,639
294,769
452,408
---------
---------
---------
Carrying amount
At 20 June 2019
119,435
61,314
180,749
---------
---------
---------
At 30 September 2018
111,487
77,417
188,904
---------
---------
---------
7. Investments
Other loans
£
Cost
At 1 October 2018
17,671
Additions
1
--------
At 20 June 2019
17,672
--------
Impairment
At 1 October 2018 and 20 June 2019
--------
Carrying amount
At 20 June 2019
17,672
--------
At 30 September 2018
17,671
--------
8. Debtors
20 Jun 19
30 Sep 18
£
£
Trade debtors
221,976
215,481
Other debtors
91,435
82,033
---------
---------
313,411
297,514
---------
---------
9. Creditors: amounts falling due within one year
20 Jun 19
30 Sep 18
£
£
Trade creditors
207,953
150,419
Corporation tax
90,341
52,739
Social security and other taxes
91,115
98,289
Directors' Current Accounts
2,544
80
Bank Overdraft
74,613
Other creditors
97,362
42,842
---------
---------
489,315
418,982
---------
---------
10. Creditors: amounts falling due after more than one year
20 Jun 19
30 Sep 18
£
£
Other creditors
1,167
12,145
-------
--------
11. Financial instruments at fair value
Financial assets measured at fair value through profit or loss
2019 2018
Unlisted investments 17,672 17,671
12. Leasing agreements
Leasing Agreements
Minimum lease payments fall due as follows:
Hire Purchase Contracts
2019 2018
Net obligations repayable
Within one year 15,917 23,141
Between two and five years 1,167 12,145
Non cancellable
operating leases
2019 2018
Annual net obligations
repayable:
Between two and five years 67,360 67,360
13. Related party transactions
During the year the company entered into the following transactions with related parties:
Transaction Value
2019 2018
SC Gough & CM Luckhurst 50,520 67,360
14. Controlling party
At the balance sheet date, the company's immediate controlling party was VetPartners Limited, whose ultimate controlling parent undertaking was BC European Capital X, a collection of Limited Partnerships with no single controlling entity.